Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-23-001983
Filing Date
2023-03-13
Accepted
2023-03-13 06:06:58
Documents
42
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K soulbiotech_10k.htm   iXBRL 10-K 597271
2 EXHIBIT 21.1 soulbiotech_ex21-1.htm EX-21.1 1820
3 EXHIBIT 31.1; EXHIBIT 31.2 soulbiotech_ex31-1.htm EX-31.1 19841
4 EXHIBIT 32.1; EXHIBIT 32.2 soulbiotech_ex32-1.htm EX-32.1 8569
  Complete submission text file 0001829126-23-001983.txt   2439461

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adob-20221231.xsd EX-101.SCH 17577
6 XBRL CALCULATION FILE adob-20221231_cal.xml EX-101.CAL 30200
7 XBRL DEFINITION FILE adob-20221231_def.xml EX-101.DEF 58328
8 XBRL LABEL FILE adob-20221231_lab.xml EX-101.LAB 163492
9 XBRL PRESENTATION FILE adob-20221231_pre.xml EX-101.PRE 133829
36 EXTRACTED XBRL INSTANCE DOCUMENT soulbiotech_10k_htm.xml XML 203099
Mailing Address 36 FOURTH AVE. N SASKATCHEWAN A9 S3N 2V7
Business Address 36 FOURTH AVE. N SASKATCHEWAN A9 S3N 2V7 (516) 544-2812
Soul Biotechnology Corp (Filer) CIK: 0001726822 (see all company filings)

EIN.: 823155323 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56213 | Film No.: 23725573
SIC: 2833 Medicinal Chemicals & Botanical Products